Clinical Trial Update: A Comparison of the Pharmacokinetic Properties of ARN-75039 Tablets With Excipients to Neat ARN-75039 in Hydroxypropyl Methylcellulose (HPMC) Capsules in Healthy Adult Participants Under Fed Conditions [Phase 1]

View source ↗

Summary

This Phase 1 pharmacokinetic study compared ARN-75039 tablets with excipients to neat ARN-75039 in hydroxypropyl methylcellulose capsules under fed conditions i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lassa Fever

Drugs mentioned

• ARN-75039

Snippet

Sponsor: Arisan Therapeutics, Inc. | Conditions: Lassa Virus Infection | Phase 1 | Status: COMPLETED